Evidence map›Paper›PMID 34911441›Full record

ArticleBMC family practice2021

Willingness, beliefs, and barriers regarding the COVID-19 vaccine in Saudi Arabia: a multiregional cross-sectional study.

Noura Altulahi, Shouq AlNujaim, Azzam Alabdulqader, Abdullah Alkharashi, Assaf AlMalki, Faisal AlSiari, Yara Bashawri, Sarah Alsubaie, Dayel AlShahrani, Yara AlGoraini

Open access · goldAbstract read
In one paragraph

Article in BMC family practice, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 4 pooled it
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 4 syntheses or guidelines pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Nirmatrelvir combined with ritonavir for preventing and treating COVID-19.The Cochrane database of systematic reviews · 2023
    Pooled it
  4. Nirmatrelvir combined with ritonavir for preventing and treating COVID-19.The Cochrane database of systematic reviews · 2022
    Pooled it
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Noura AltulahiCollege of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
Shouq AlNujaimCollege of Medicine, King Saud Bin Abdul-Aziz University for Health Sciences, Riyadh, Saudi Arabia.
Azzam AlabdulqaderCollege of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.
Abdullah AlkharashiCollege of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.
Assaf AlMalkiCollege of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.
Faisal AlSiariCollege of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.
Yara BashawriBiostatistics Specialist, Biostatistics Department, King Fahad Medical City, Research Services Administration, Riyadh, Saudi Arabia.
Sarah AlsubaieDepartment of Pediatrics, College of Medicine, Pediatric Infectious Diseases and Infection Control, King Saud University, Riyadh, Saudi Arabia.
Dayel AlShahraniPediatric Infectious Diseases, Pediatric Infectious Diseases Section, King Fahad Medical City, Riyadh, Saudi Arabia.
Yara AlGorainiPediatric Emergency Department, King Fahad Medical City, Riyadh, Saudi Arabia. Yalgoraini@Kfmc.Med.Sa.
Imam Abdulrahman Bin Faisal University · SAKing Fahd Medical City · SAKing Saud University · SAKing Saud bin Abdulaziz University for Health Sciences · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe coronavirus disease 2019 (COVID-19) has spread worldwide, and the vaccine remains the ultimate cornerstone to overcoming its long-term impact. Vaccine hesitancy might obstruct the effort to achieve herd immunity and eradicate the virus. We assessed Saudi Arabian individuals' willingness, beliefs, and barriers regarding the COVID-19 vaccine and their adherence to preventive measures during and after the pandemic.

methodsA self-administered electronic validated questionnaire was distributed among the five major regions in Saudi Arabia between November and December 2020. The questionnaire addressed the sociodemographic data, beliefs, potential barriers, parents' acceptance of COVID-19 vaccination for their children, and adherence to protective measures during and after the pandemic.

resultsOf 8,056 participants, 4,218 (52.4%) of a non-representative sample were willing to be vaccinated against COVID-19. Being a young adult, male, having less than a high school degree, being a smoker, having a chronic disease, and having a history of seasonal influenza vaccine uptake were positive predictors of COVID-19 vaccine acceptance. Hesitant participants reported concerns about vaccine side effects and safety as the main barriers to accepting the COVID-19 vaccine. Some refusers (26.1%) declared that they would reconsider vaccination only if the safety and effectiveness of the vaccine were reported by more studies.

conclusionsOur study revealed a promising willingness to accept the vaccine among the population, with positive beliefs and attitudes toward COVID-19 vaccination. However, a considerable proportion of the population was reluctant to accept the vaccine. Thus, publicly providing information about vaccine safety and implementing health education programs is crucial for increasing the public's confidence in the vaccine.

Indexed as

COVID-19COVID-19 VaccinesChildCross-Sectional StudiesHumansMaleSARS-CoV-2Saudi ArabiaVaccination HesitancyYoung AdultCOVID-19 VaccinesBarriersBeliefsSaudi ArabiaVaccinationWillingness COVID-19 vaccine

Identifiers

PMID34911441
PMCPMC8674018
OpenAlexW4200338098

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.